Merck & Co., Inc. invites residents of the United States to access and use this Internet site subject to the terms and conditions below and all applicable laws. This site and all information contained therein are intended for access and use by such residents only.
The entire content of this site is subject to copyright protection. Copyright © 2011 N.V. Organon, a subsidiary of Merck & Co., Inc. All rights reserved.
You may download and retain on your disk or in hard copy form a single copy of material published on this site for your personal use, provided that you do not remove any proprietary notices. You may not otherwise copy, distribute, display, download, modify, or repost all or part of any material without Merck & Co., Inc.'s written permission. You may not mirror on another Web server all or part of any material published by Merck & Co., Inc. on this site, and you may not inline any of the graphics contained in any material published on this site.
Merck & Co., Inc. will use reasonable efforts to include accurate and up-to-date information on this site, but makes no representations or warranties as to its accuracy or completeness. Access to and use of the content is at your own risk, and neither Merck & Co., Inc. nor any party involved in creating or delivering this site shall be liable to you for any damage of any kind arising out of your access, use or inability to access or use this site, or for any omissions or errors in its content.
Merck & Co., Inc. reserves the right to alter or delete material from this site at any time.
Merck & Co., Inc. may revise these terms and conditions periodically.
Prescription NuvaRing is a flexible vaginal ring approved for the prevention of pregnancy in women.
Important Safety Information
Cigarette smoking increases the risk of serious cardiovascular side effects when you use combination oral contraceptives. This risk increases even more if you are over age 35 and if you smoke 15 or more cigarettes a day. Women who use combination hormonal contraceptives, including NuvaRing, are strongly advised not to smoke.
- The use of combination oral contraceptives is associated with increased risks of several serious side effects, including blood clots, stroke, or heart attack. NuvaRing is not for women with a history of these conditions. The risk of getting blood clots may be greater with the type of progestin in NuvaRing than with some other progestins in certain low-dose birth control pills. It is unknown if the risk of blood clots is different with NuvaRing use than with the use of certain birth control pills.
- NuvaRing is not for women with certain cancers or those who may be pregnant.
- NuvaRing does not protect against HIV infection and other sexually transmitted diseases.
- The most common side effects reported by NuvaRing users are: vaginal infections and irritation, vaginal secretion, headache, weight gain, and nausea.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please read the Patient Information for NuvaRing, including the information about the increased risk of serious cardiovascular side effects, especially in women who smoke, and discuss it with your doctor. The physician Prescribing Information is also available.
Back to top